Vera Therapeutics (VERA) Prepaid Assets (2020 - 2026)
Vera Therapeutics posted quarterly Prepaid Assets of $2.5 million for Q1 2026, down 84.61% year-on-year from $16.2 million in Q1 2025, and down 82.52% on a QoQ basis from $14.3 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 84.61% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (down 84.61% YoY), and the FY2025 full-year result was $14.3 million, up 1916.08% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.5 million, down from $14.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $16.2 million in Q1 2025 and bottomed at $247000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $1.2 million (2024), against an average of $4.5 million.
- The widest annual swing landed in 2025, when Prepaid Assets surged 1916.08%; it then tumbled 84.61% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $247000.0 in 2022, then grew by 4.05% to $257000.0 in 2023, then surged by 175.88% to $709000.0 in 2024, then soared by 1916.08% to $14.3 million in 2025, then tumbled by 82.52% to $2.5 million in 2026.
- The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $14.3 million (Q4 2025), and $13.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 13.92 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 16.24 Mn |
| Dec 31, 2024 | 709,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 12.71 Mn |
| Dec 31, 2023 | 257,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 7.30 Mn |
| Dec 31, 2022 | 247,000.00 |
| Sep 30, 2022 | 792,000.00 |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | 452,000.00 |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 3.57 Mn |
| Jun 30, 2021 | 475,000.00 |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 557,000.00 |